Concentration: 1.0 mg/mL in 1 mM Sodium Citrate, pH 6.4.
mRNA length: 1915 nt.
MW MRNA49= 619220 g/mol; MRNA50= 627410 g/mol; MRNA51= 623315 g/mol.
HA-H3N2 mRNA has been designed to produce high expression level of the (HA) hemagglutinin surface glycoproteins of H3N2 subtype of Influenza A virus.
OZB mRNAs are produced by in vitro transcription. mRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3’ end. Sequences have been optimized to yield improved stability and performance.
HA-H3N2 mRNAs:
-
#MRNA49 does not bear any additional nucleotide modifications.
-
#MRNA50 is modified with 5-methoxyuridine (5moU) to reduce innate immune response.
-
#MRNA51 is modified with N1-methyl-pseudouridine (N1-mψ) to reduce innate immune response.
Size: 20 µg, 100µg or 1 mg.
Storage: -80°C
mRNAs ARE SHIPPED WITH DRY ICE
| CATALOG NUMBER |
UNIT SIZE |
| MRNA49-20 |
Unmodified HA-H3N2 mRNA 20 µg
|
| MRNA49-100 |
Unmodified HA-H3N2 mRNA 100 µg
|
| MRNA49-1000 |
Unmodified HA-H3N2 mRNA 1 mg
|
| MRNA50-20 |
HA-H3N2 mRNA (5moU) 20 µg
|
| MRNA50-100 |
HA-H3N2 mRNA (5moU) 100 µg
|
| MRNA50-1000 |
HA-H3N2 mRNA (5moU) 1 mg
|
| MRNA51-20 |
HA-H3N2 mRNA (N1-mψ) 20 µg
|
| MRNA51-100 |
HA-H3N2 mRNA (N1-mψ) 100 µg
|
| MRNA51-1000 |
HA-H3N2 mRNA (N1-mψ) 1 mg
|
SingaporeSG
ChinaCN
MalaysiaMY
IndonesiaID
MyanmarMM_pddqnqv8.png)
_prfhitzk.jpg)
_5jb0on5i.jpg)